comprehensive -WSS

comprehensive

author：focus 2025-09-29 21:28:41 - browse：356

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Readout Newsletter: Merck, Vertex, and Viking updates

knowledge

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Abortion pill Supreme Court ruling could impact entire drug industry

Decaf coffee targeted by food safety group under obscure FDA rule

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Food as medicine: Medically tailored meals may get standardized

Wikipedia

comprehensive

knowledge

Virginia high school admissions case could be legal follow

Scientists boost immune system in aging mice by making it youthful

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD podcast: mifepristone case, GLP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Bright Health sells Medicare Advantage business to Molina

Primary care physicians play key roles in Alzheimer's management

Wildfire smoke exposes gaps in outdoor worker protections

Abortion pill Supreme Court ruling could impact entire drug industry

hotspot

The Readout: Lenmeldy, GLP

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Why the world’s most expensive drug might be worth the price

States should stop sabotaging methadone treatment reform

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Readout Newsletter: Merck, Vertex, and Viking updates

hotspot

Wikipedia

knowledge

hotspot